De-Risky Business: Assessing Biotherapeutic Off-Target and On-Target Liabilities

Toxicity failures caused by off-target or unintended on-target liabilities are a leading cause of attrition in clinical and preclinical programs. Given the effort, cost, and technical limitations of traditional biopharmaceutical de-risking strategies, there is a need for a robust and scalable approach that can be rapidly applied to the discovery phases of therapeutic programs. Join us for this exciting new GEN Webinar, where our panel of experts will discuss new approaches to de-risking lead selection of antibodies and other biotherapeutics.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Cardiovascular medicine A look inside the CVOR

In this SelectScience webinar, Robert Stroud, Chief of Perfusion at the Maimonides Medical Center, will focus on the cardiovascular operating room (CVOR) and the challenges experienced throughout the various procedures.
Watch Now

Biometrics - The future of web and mobile authentication

techgig

Bio-metrics authentication is fast replacing passwords as the choice of authentication technique on web and mobile applications. This webinar covers various bio-metric options, comparative benefits and emerging trends.
Watch Now

VIRAL SAFETY BY DESIGN FOR CELL AND GENE THERAPY PRODUCTS

Biopharma-asia

Together with product efficacy, product safety is an essential characteristic of any medicinal product including cell and gene therapy (C>) biologics. Adventitious agents (viruses, bacteria, mycoplasma, prions, etc) pose constant risk to these biologics, and, as such they may impact directly product and patient safety.
Watch Now

Uncovering Leukemia Therapies with Single-Cell CRISPR Screens

Lack of cellular differentiation is a hallmark of many human cancers, including acute myeloid leukemia (AML). Strategies to overcome such differentiation blockade, a notion known as “differentiation therapy,” represent an alternative approach for treating a subset of AML patients, a disease marked by a dismal prognosis and limited therapeutic options.
Watch Now

Spotlight

resources